In this video, Berta Sousa, an oncologist at the Champalimaud Foundation’s Breast Unit and one of the people in charge of the BOUNCE project in Portugal, talks about the results already obtained concerning the factors that influence resilience to the diagnosis and treatments in breast cancer patients.  She also evokes a study of the impact of treatments on cognitive function, specifically performed by the Breast Unit, whose results will be presented shortly.

In this video, Radiation Oncologist Javier Morales, of the Champalimaud Foundation’s (CF) Breast Unit, describes state-of-the-art breast radiotherapy treatments and equipment in use at the CF, also referring to the multidisciplinarity and personalisation of patient care. 

In this video, Radiologist Celeste Alves, who leads the Breast Unit's Radiology Service at the Champalimaud Foundation, talks about the central role of breast radiology in the Unit’s activities, be they clinical services or research projects.

Cancer survival is estimated by cancer survival rates, which represent the percentage of people who survive a certain type of cancer for a specific amount of time. The most common are the five-year and 10-year survival rates.

Many of the most commonly diagnosed cancers have 10-year survival of 50% or more. More than 80% of people diagnosed with cancer types which are easier to diagnose and/or treat survive their cancer for ten years or more.

What distinguishes the Champalimaud Foundation’s Breast Unit from other units in the same field? In this short video, Fátima Cardoso, who leads the Breast Unit at the Champalimaud Foundation, answers this question.

October is World Breast Cancer Awareness Month. Fátima Cardoso, who leads the Breast Unit at the Champalimaud Foundation, presents here a series of short videos that will be published all through this month of October about the Breast Unit, its clinical activities and its research projects.

This public event, organised by the RAISE (Researchers in Action for Inclusion in Science and Education) consortium composed of the NGO Native Scientist, the Champalimaud Foundation and the Instituto de Medicina Molecular João Lobo Antunes (iMM), joined the 49 ERNs that took place in 25 European countries on the same date.

On September 15th 2022, the António Champalimaud Vision Award was attributed to two physician-scientists, both of them ophthalmologists, for their pioneering work in the understanding and treatment of corneal disease. Gerrit Melles from the Netherlands Institute for Innovative Ocular Surgery, and Claes Dohlman, from Mass Eye & Ear and Harvard University, shared the prestigious one million euro award – the former for his innovative surgical methods of corneal transplant, the latter for his advancement of cornea research and the development of an artificial cornea, the “Boston K-Pro”.

Organised by Broadreach Global with the European Brain Foundation (EBC), this summit will  bring together - in a collaborative, roundtable format - a highly diverse group of key opinion leaders, from  innovators, to decision-makers.